BUSINESS
J&J’s move to exit talc globally need not raise any fresh concerns
India's drug regulator could be pulled up for several lapses, but in the J&J talc case, it has ticked the boxes
HEALTH-TRENDS
Extension of Covaxin’s shelf life has been mishandled
However well-intended it may be, the attempt to salvage every vaccine dose was ill thought-through
BUSINESS
For now, a middle ground in Indian healthcare
Make private investment in healthcare work more and better
